RxDoctor Payments Data

Samuel Hoeper

Internal Medicine · Kansas City, MONPI 1700877792

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 158 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 14.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $956 and has fallen 63.3% since, to $351 in 2022.

$2,239in general payments, 2019–2025

Across 158 payments — averaging $14.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$325
  • Pfizer$303
  • Amgen$231
  • Novo Nordisk$187
  • AbbVie$152
  • Boehringer Ingelheim$124
  • plus $916 from 20 others

What the payments were for

  • Food & beverage$2,239100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,239 in reported general payments places this provider in the 80th percentile of 2,097 internal medicine providers in Missouri.

See all internal medicine providers in Missouri →

Other internal medicine in Kansas City

See the full list for Missouri →

Where these figures come from

Is this you, or does something look wrong? →